Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of different doses of granisetron on prevention of postoperative shivering in septoplasty
IRCT201411173915N11Phase 3Completed
- Sponsor
- Research Deputy of Tabriz University of Medical Sciences
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of granisetron in postanesthetic shivering (PAS) (2 arms), sponsored by Research Deputy of Tabriz University of Medical Sciences. Primary endpoint: Incidence of postoperative shivering. Started Mar 2014; status: completed.
02
Drugs
granisetron
03
Conditions
postanesthetic shivering (PAS)
Beyond the preview
Go deeper on IRCT201411173915N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201411173915N11.